Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 06, 2023

SELL
$191.51 - $216.16 $11 Million - $12.4 Million
-57,537 Reduced 96.76%
1,925 $408,000
Q2 2023

Aug 03, 2023

SELL
$187.64 - $206.25 $3.19 Million - $3.51 Million
-17,022 Reduced 22.26%
59,462 $11.4 Million
Q1 2023

May 04, 2023

BUY
$127.59 - $203.08 $4.58 Million - $7.29 Million
35,875 Added 88.34%
76,484 $15.5 Million
Q4 2022

Feb 06, 2023

BUY
$117.37 - $139.17 $1.48 Million - $1.76 Million
12,629 Added 45.14%
40,609 $5.22 Million
Q3 2022

Nov 02, 2022

BUY
$135.27 - $180.11 $3.78 Million - $5.04 Million
27,980 New
27,980 $3.83 Million
Q2 2022

Aug 05, 2022

SELL
$108.81 - $179.33 $152,878 - $251,958
-1,405 Closed
0 $0
Q1 2022

May 06, 2022

SELL
$119.61 - $157.85 $3.12 Million - $4.12 Million
-26,081 Reduced 94.89%
1,405 $202,000
Q4 2021

Feb 03, 2022

SELL
$142.57 - $190.86 $17 Million - $22.8 Million
-119,420 Reduced 81.29%
27,486 $4.25 Million
Q3 2021

Nov 08, 2021

BUY
$142.45 - $169.82 $20.4 Million - $24.4 Million
143,454 Added 4155.68%
146,906 $24.9 Million
Q2 2021

Aug 05, 2021

SELL
$135.08 - $161.1 $368,633 - $439,641
-2,729 Reduced 44.15%
3,452 $545,000
Q1 2021

May 05, 2021

SELL
$137.51 - $190.8 $5.49 Million - $7.62 Million
-39,943 Reduced 86.6%
6,181 $858,000
Q4 2020

Feb 04, 2021

BUY
$164.63 - $211.93 $7.59 Million - $9.78 Million
46,124 New
46,124 $8.08 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.